StockData
Lantheus Holdings, Inc. logo

Lantheus Holdings, Inc. (LNTH) stock

LNTHNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 11/3012% above fair value
$101.80+0.08 (+0.08%)

Close on Nov 17, 2026Market cap $6.64BP/E 24.6Yield –

Lantheus pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Lantheus's pe ratio was 24.6× on Nov 11, 2026, against 24.6× a year earlier. Over the last 5 years it ranged from 12.3× to 213.6×, with a median of 24.1×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202624.6×−3.2
2025Dec 31, 202527.8×+13.0
2024Dec 31, 202414.9×−27.0
2023Dec 29, 202341.9×+7.7
2022Dec 30, 202234.2×−169.2
2021Jan 29, 2021203.4×+34.8
2020Dec 31, 2020168.6×+145.1
2019Dec 31, 201923.6×+18.6
2018Dec 31, 20184.9×−20.3
2017Dec 29, 201725.2×+15.0
2016Dec 30, 201610.2×–

More Lantheus figures

See a number that looks wrong?